Efficacy and safety of artesunate for patients with iga nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial

HIGHLIGHTS

• who: Qi Chen from the Department of Nephrology, Dongzhimen Hospital, The First Affiliated Hospital of Beijing University of Chinese Medicine, No, Haiyuncang, Dongcheng District, Beijing, China have published the article: Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial, in the Journal: (JOURNAL) of 10/09/2020
• what: Dropout criteria Patients who refuse to participate in the study visits for personal reasons or those whom the researchers are unable to contact through all available means will be regarded as dropouts.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.